DoubleChecks

What was claimed

Ivermectin + fenbendazole + MCP + CBD caused CA19-9 tumor marker to drop from 35,000 to 8,000 in a stage 4 pancreatic cancer patient after 3 months (far better than chemo); repurposed drugs beat Big Pharma's overhyped cures

Our verdict

Inaccurate

No reliable source supports the claim that this regimen is better than chemotherapy. Medical sources state there is no scientific proof that these antiparasitic drugs treat pancreatic cancer in people, and no clinical trials have established comparative benefit. No clinical trial evidence exists for ivermectin, fenbendazole, MCP, or CBD as treatments for pancreatic cancer. Anecdotal case reports do not constitute clinical evidence of efficacy. (Only 2 of 3 AI systems responded.)

1 of 2 AI systems agree15 sources citedChecked Sep 2, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

This outcome is far better than chemotherapy

Incorrect90%
All 2 AIs agree

These drugs are effective for stage 4 pancreatic cancer

Incorrect92%
1 AI checked

Repurposed drugs beat Big Pharma's overhyped cures.

Misleading92%
All 2 AIs agree

Ivermectin + fenbendazole + MCP + CBD caused CA19-9 to drop from 35,000 to 8,000 in a stage 4 pancreatic cancer patient after 3 months.

Can’t verify73%
All 2 AIs agree

Verified against 15 sources

onedaymd.substack.commakisw.substack.comcancer.aestheticsadvisor.comonedaymd.comwebmd.com2ndsmartestguyintheworld.comsmartcancer.orgfenbendazole.substack.comcancer.aestheticsadvisor.comoncodaily.comonedaymd.compmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govtruth613.substack.compmc.ncbi.nlm.nih.gov

Detailed Analysis

The specific testimonial about a stage 4 pancreatic cancer patient whose CA19-9 fell from 35,000 to 8,000 after 3 months on ivermectin, fenbendazole, MCP, and CBD is supported only by a recent Substack-style testimonial, not by independent clinical evidence. Current medical sources say there is no scientific proof that ivermectin, fenbendazole, or similar antiparasitic drugs treat pancreatic cancer in people, and no clinical trials have established them as effective or safer than chemotherapy.

Why this verdict

  • The specific testimonial about a stage 4 pancreatic cancer patient whose CA19-9 fell from 35,000 to 8,000 after 3 months on ivermectin, fenbendazole, MCP, and CBD is supported only by a recent Substack-style testimonial, not by independent clinical evidence.
  • Current medical sources say there is no scientific proof that ivermectin, fenbendazole, or similar antiparasitic drugs treat pancreatic cancer in people, and no clinical trials have established them as effective or safer than chemotherapy.

Claims checked

This result was far better than chemo.

Incorrect90%
No reliable source supports the claim that this regimen is better than chemotherapy. Medical sources state there is no scientific proof that these antiparasitic drugs treat pancreatic cancer in people, and no clinical trials have established comparative benefit.

This claim may mislead readers without added context.

Repurposed drugs beat Big Pharma's overhyped cures.

Misleading96%
This is a broad promotional claim, not a verifiable medical fact. Current medical sources do not support the idea that these repurposed drugs outperform standard cancer therapies.

This claim may mislead readers without added context.

Ivermectin + fenbendazole + MCP + CBD caused CA19-9 to drop from 35,000 to 8,000 in a stage 4 pancreatic cancer patient after 3 months.

Can’t verify61%
A recent testimonial reports this exact outcome, but it is not independently verified by clinical records or peer-reviewed evidence. The claim cannot be confirmed from authoritative sources.

What other AI think

The statement presents an unverified anecdotal case as fact and makes unsupported comparative claims about treatment efficacy. While CA19-9 marker drops can indicate treatment response, the specific case lacks clinical documentation, and the claim that this outcome is "far better than chemo" cannot be verified without survival data. No clinical trial evidence supports the drug combination's efficacy.

Why this verdict

  • The statement presents an unverified anecdotal case as fact and makes unsupported comparative claims about treatment efficacy.
  • While CA19-9 marker drops can indicate treatment response, the specific case lacks clinical documentation, and the claim that this outcome is "far better than chemo" cannot be verified without survival data.
  • No clinical trial evidence supports the drug combination's efficacy.

Claims checked

This outcome is far better than chemotherapy

Incorrect90%
The claim cannot be substantiated. A CA19-9 drop alone does not prove superior outcomes. Standard chemotherapy for stage 4 pancreatic cancer shows that 90% CA19-9 reduction correlates with 13.5 months median survival. No survival data is provided for the claimed case, making the comparison invalid.

This claim may mislead readers without added context.

These drugs are effective for stage 4 pancreatic cancer

Incorrect92%
No clinical trial evidence exists for ivermectin, fenbendazole, MCP, or CBD as treatments for pancreatic cancer. Anecdotal case reports do not constitute clinical evidence of efficacy.

This claim may mislead readers without added context.

Repurposed drugs beat Big Pharma's overhyped cures

Misleading88%
This is a rhetorical claim without evidence. No clinical trials demonstrate these repurposed drugs are effective for pancreatic cancer. The statement conflates anecdotal reports with proven efficacy and uses inflammatory language rather than evidence-based comparison.

This claim may mislead readers without added context.

ChatGPTDid not respond

Share this result

Try DoubleChecks